Anthropic Sets $70-$78 IPO Range: What Retail Investors Should Know

Anthropic has put a price on its Nasdaq debut. In an updated filing Tuesday, the AI lab said it will offer 825 million shares at $70 to $78 each, and it plans to trade under the ticker ANT.

People familiar with the plan told CNBC that pricing is set for Nov. 18, with trading starting Nov. 19.

At the top of the range, the company would net up to $64.35 billion and carry a fully diluted value of about $1.405 trillion.

That's well above the $965 billion valuation from its May funding round. It's also a long way from the $2 trillion some shareholders were eyeing until recently. One investor told CNBC that even $1.5 trillion had become a "stretch."

The share count breaks down like this, according to Anthropic's roadshow announcement: 801,351,354 shares come from the company, and 23,648,646 come from existing stockholders who keep those proceeds. Underwriters also get a 30-day option on up to 123.75 million more shares.

Now the financials. For the nine months ended Sept. 30, Anthropic reported $33.24 billion in revenue, up roughly 1,200% from the same period a year earlier.

The bottom line is ugly, though. Net loss hit $104 billion, versus $25.1 billion a year earlier, but most of it came from changes in the fair value of convertible notes and derivative liabilities rather than day-to-day operations.

There's a quirk in who's buying, too. AMD, Broadcom, Google, Micron, Microsoft, Nvidia and Taiwan Semiconductor agreed to buy $26 billion of Class N stock in a private placement at the IPO price. Those shares aren't registered in the offering and aren't subject to lock-up agreements.

Anthropic said its run-rate revenue was roughly $81 billion at the end of October, up $10 billion from the previous month.

For everyday investors, the headline is allocation. Anthropic is reportedly targeting about 20% for retail, against the 5% to 10% that's typical in an IPO. The same sources say the book is already covered at the range on an allocable basis.

Translation: demand looks strong, but a bigger retail slice doesn't mean you'll get shares. Ask your broker now whether it's participating, how it decides who gets allocations, and what account requirements apply.

Strong demand has a flip side. The market has grown skeptical of the AI trade, partly on worries that rising interest rates will make the debt behind costly infrastructure harder to carry.

Last week's midterms added another layer of uncertainty, with a Democratic sweep in Congress and statewide ballot measures that could slow the AI buildout.

Then there's the valuation. Even at the low end of the range, you're paying for years of growth that hasn't happened yet, and the $81 billion run-rate figure is a snapshot, not a guarantee. Those unlocked placement shares are also worth watching, since supply can matter once trading starts.

SpaceX offers a useful comparison. It went public about five months ago in a record offering that raised $85.7 billion, and its market cap today sits just under $2 trillion, around where it was valued at the IPO. A hot debut isn't automatically a durable trade.

Here's what to watch. Where Anthropic prices on Nov. 18 (above, inside or below the range) tells you a lot about real demand. So does how the stock trades on day one versus the days after.

If you do try for shares, use a limit order rather than a market order on opening day, and size the position so a 30% swing wouldn't hurt. If you can't get an allocation, remember the placement buyers are public companies you can already own.

Bottom line: a covered book and a big retail slice make this a headline event, but price discipline matters more than getting in the door.